BPC-157 stands out for its stability in stomach acid and its broad gastrointestinal record, while TB-500 stands out for its actin-regulation mechanism and wound-closure data
The acronym is a trade-name convention rather than a regulated formulation
This review aims to fill these gaps by offering a comprehensive assessment of GSHs dual role in cancer biology, systematically examining nanotechnology-enabled approaches (such as disulfide and diselenide linkages, transition metal systems, and prodrugs), and critically evaluating their strengths, limitations, and potential for clinical translation
It is not approved by major health authorities for medical use, and its safety, dosage, and long-term effects are not well established
Scientific References 5 sources 1 U.S